相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy
Sotirios Tsiodras et al.
MAYO CLINIC PROCEEDINGS (2012)
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
D. Salmon-Ceron et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Etanercept An Overview of Dermatologic Adverse Events
Lidian L. A. Lecluse et al.
ARCHIVES OF DERMATOLOGY (2011)
Treatment Response, Drug Survival, and Predictors Thereof in 764 Patients With Psoriatic Arthritis Treated With Anti-Tumor Necrosis Factor α Therapy Results From the Nationwide Danish DANBIO Registry
Bente Glintborg et al.
ARTHRITIS AND RHEUMATISM (2011)
Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events A Meta-analysis of Randomized Controlled Trials
Caitriona Ryan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Carlos G. Grijalva et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the literature
C. Fotiadou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Etanercept Therapy for Psoriasis in a Patient with Active Pulmonary Tuberculosis
Ran Huo et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2010)
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
X. Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Is Etanercept Safe for Treating Plaque Psoriasis in a Patient With Chronic Hepatitis C Virus Infection?
Rishi K. Gandhi et al.
ARCHIVES OF DERMATOLOGY (2010)
Fatal Influenza A(H1N1) Respiratory Tract Infection in a Patient Having Psoriasis Treated With Infliximab
Maxwell C. Kling et al.
ARCHIVES OF DERMATOLOGY (2010)
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
Fabiola Atzeni et al.
AUTOIMMUNITY REVIEWS (2010)
Antinuclear antibodies associate with loss of response to antitumour necrosis factor-α therapy in psoriasis: a retrospective, observational study
A. E. Pink et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
R. G. Langley et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents
Wolfgang Weger
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Treatment of Psoriasis with Anti-TNF Drugs during Pregnancy: Case Report and Review of the Literature
Lluis Puig et al.
DERMATOLOGY (2010)
Progressive Multifocal Leukoencephalopathy and Newer Biological Agents
Joseph R. Berger
DRUG SAFETY (2010)
A safety assessment of tumor necrosis factor antagonists during pregnancy
Vanessa C. Osting et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Infliximab and anterior optic neuropathy: case report and review of the literature
Jane W. Chan et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Infliximab-related hepatitis: discussion of a case and review of the literature
Stefano Mancini et al.
INTERNAL AND EMERGENCY MEDICINE (2010)
Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis
Jaffar A. Al-Tawfiq et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Lymphoma, rheumatoid arthritis, and TNF alpha antagonists
Xavier Mariette
JOINT BONE SPINE (2010)
Transient and reversible thrombocytopenia in a psoriatic patient treated with etanercept
Nicola Balato et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2010)
Listeria endocarditis in a patient with psoriatic arthritis on infliximab: Are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?
Theodoros Kelesidis et al.
JOURNAL OF INFECTION (2010)
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
Batya B. Davidovici et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Neurological adverse events associated with anti-tumor necrosis factor alpha treatment
Antonio G. Tristano
JOURNAL OF NEUROLOGY (2010)
Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation
Kavita Menon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
TNF-α antagonists beyond approved indications: stories of success and prospects for the future
M. P. Karampetsou et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register
Amr A. Saad et al.
RHEUMATOLOGY (2010)
Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
Angelique N. Collamer et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
EFFICACY AND SAFETY OF BIOLOGICALS AGAINST IMMUNE-MEDIATED DISEASES: DO BENEFITS OUTWEIGH RISKS?
L. Korkina et al.
DRUGS OF TODAY (2010)
Leukemic Phase of Follicular Lymphoma after Treatment with Etanercept in a Patient with Psoriasis
Siddhartha Ganguly
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2009)
From Randomized Controlled Trials to Observational Studies
Stuart L. Silverman
AMERICAN JOURNAL OF MEDICINE (2009)
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
J. Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Drug-induced lupus erythematosus
Camilla Dalle Vedove et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2009)
Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
Pierre Lozeron et al.
ARCHIVES OF NEUROLOGY (2009)
Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
F. Tubach et al.
ARTHRITIS AND RHEUMATISM (2009)
Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians
A. Perlmutter et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma
B. F. Chong et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Acute bilateral phrenic neuropathy following treatment with adalimumab
Alexandra Alexopoulou et al.
CLINICAL RHEUMATOLOGY (2009)
Long-term efficacy of biologics in dermatology
Leslie Castelo-Soccio et al.
DERMATOLOGIC THERAPY (2009)
New biologics for psoriasis and psoriatic arthritis
Mariya Rozenblit et al.
DERMATOLOGIC THERAPY (2009)
SUCCESSFUL TREATMENT WITH ETANERCEPT OF A PATIENT WITH PSORIATIC ARTHRITIS AFTER ADALIMUMAB-RELATED HEPATOTOXICITY
M. Massarotti et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti-TNF-α Agents
Anja Strangfeld et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature
Jean-Marie Berthelot et al.
JOINT BONE SPINE (2009)
Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans
Heiko Bruns et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
Justin M. Ko et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2009)
Axonal Common Peroneal Nerve Palsy and Delayed Proximal Motor Radial Conduction Block Following Infliximab Treatment
Andreas A. Argyriou et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Thrombocytopenia associated with the use of anti-tumor necrosis factor-α agents for psoriasis
Alexandra Maria Giovanna Brunasso et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation
Amylynne J. Frankel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
The role of case reports in evidence-based practice, with suggestions for improving their reporting
Joerg Albrecht et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Cutaneous side effects of anti-tumor necrosis factor biologic therapy: A clinical review
Aikaterini-Evaggelia Moustou et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Psoriasis and systemic inflammation: underdiagnosed enthesopathy
G. Girolomoni et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors
S. A. Exarchou et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Psoriasis and Atherothrombotic Diseases: Disease-Specific and Non-Disease-Specific Risk Factors
Paolo Gisondi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
Amr A. Saad et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Cytomegalovirus complicating biological immunosuppressive therapy in two patients with psoriasis receiving treatment with etanercept or efalizumab
Bibi Petersen et al.
ACTA DERMATO-VENEREOLOGICA (2008)
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
V. Ravindran et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus
Maryann Mikhail et al.
ARCHIVES OF DERMATOLOGY (2008)
Etanercept-Induced Lupus Erythematosus Presenting as a Unilateral Pleural Effusion
Jafar Abunasser et al.
CHEST (2008)
The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
Johan Askling et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Rapid onset and fatal outcome of two squamous cell carcinomas of the genitalia in a patient treated with etanercept for cutaneous psoriasis
Christelle Comte et al.
DERMATOLOGY (2008)
Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis
Francesca Fantuzzi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Effect of etanercept plus lamivudine in a patient with rheumatoid arthritis and viral hepatitis B
Maurizio Benucci et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy
Alexander Winkelmann et al.
JOURNAL OF NEUROLOGY (2008)
Hepatotoxicity Associated with Etanercept in Psoriatic
Alison M. Leak et al.
JOURNAL OF RHEUMATOLOGY (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics
Alice Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
De testimonio: on the evidence for decisions about the use of therapeutic interventions
Michael Rawlins
LANCET (2008)
Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient
Pilar Martinez Montiel et al.
LIVER INTERNATIONAL (2008)
The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease
E. J. Cepeda et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Pulmonary sarcoidosis associated with etanercept therapy
Raymond E. Farah et al.
PHARMACOTHERAPY (2007)
Biologic treatment of rheumatoid arthritis and the risk of malignancy - Analyses from a large US observational study
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
Biologic therapies in psoriasis: A new therapeutic approach
Paolo Gisondi et al.
AUTOIMMUNITY REVIEWS (2007)
Autoimmune diseases induced by TNF-targeted therapies -: Analysis of 233 cases
Manuel Ramos-Casals et al.
MEDICINE (2007)
Meta-analysis is no substitute for a comprehensive national registry
Magdalena Dziadzio et al.
CLINICAL RHEUMATOLOGY (2007)
Long-term anti-TNFα therapy for ankylosing spondylitis in two patients with chronic HBV infection
Grigorios T. Sakellariou et al.
CLINICAL RHEUMATOLOGY (2007)
Reactivation of latent tuberculosis by TNF blockade:: The role of interferon γ
Robert S. Wallis
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2007)
Effects of etanercept are distinct from infliximab in modulating proinflammatory genes in activated human leukocytes
Asifa S. Haider et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2007)
Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab
Angel M. Garcia Aparicio et al.
CLINICAL RHEUMATOLOGY (2007)
Infections during tumour necrosis factor-α blocker therapy for rheumatic diseases in daily practice:: a systematic retrospective study of 709 patients
C. Salliot et al.
RHEUMATOLOGY (2007)
The risk of lymphoma in patients with psoriasis
Joel M. Gelfand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2006)
Visual recovery following Mycobacterium chelonae endophthalmitis
MW Stewart et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Adalimumab-associated optic neuritis
Jacob H. Chung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Cost-effectiveness of moderateto-severe psoriasis treatment
DW Miller et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C
Clara De Simone et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Atypical CD8(+) cutaneous T-cell lymphoma after immunomodulatory therapy
Cindy Berthelot et al.
CLINICAL LYMPHOMA & MYELOMA (2006)
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
JJ Gomez-Reino et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER Group
Loreto Carmona et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich et al.
LANCET (2005)
Reactivation of latent granulomatous infections by infliximab
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
J Askling et al.
ARTHRITIS AND RHEUMATISM (2005)
Current severe psoriasis and the Rule of Tens
AY Finlay
BRITISH JOURNAL OF DERMATOLOGY (2005)
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
NN Zein
JOURNAL OF HEPATOLOGY (2005)
Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy
K Eisendle et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
M De Bandt et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Aggressive cutaneous T-cell lymphomas after TNFα blockade
AE Adams et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
CD30+T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab
E Mahé et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α-neutralizing agents
NR Slifman et al.
ARTHRITIS AND RHEUMATISM (2003)
Lymphoma rates are low but increased in patients with psoriasis - Results from a population-based cohort study in the United Kingdom
JM Gelfand et al.
ARCHIVES OF DERMATOLOGY (2003)
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection
JR Peterson et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor
J Kuruvilla et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration
SL Brown et al.
ARTHRITIS AND RHEUMATISM (2002)
Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept
JH Lee et al.
ARTHRITIS AND RHEUMATISM (2002)
Onset of multiple sclerosis associated with anti-TNF therapy
NL Sicotte et al.
NEUROLOGY (2001)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
VP Mohan et al.
INFECTION AND IMMUNITY (2001)
分享论文
